← Back to Clinical Trials
Recruiting NCT06431867

NCT06431867 Primary Care Management of Osteoporosis in Older Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06431867
Status Recruiting
Phase
Sponsor Bradford Institute for Health Research
Condition Osteoporosis
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-09-16
Primary Completion 2025-03

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Guidelines for primary care management of osteoporosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-09-16 with a primary completion date of 2025-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Investigators aim to improve primary-care for older women with osteoporosis. Older women they spoke with previously felt unseen, unimportant, unheard and uninformed. These women felt that bone/joint health was an important issue for women aged 70+. Osteoporosis is a disease that makes bones more breakable and can lead to significant pain, disability and death, costing approximately £4.4 billion a year in the United Kingdom. Women are four times more likely to have osteoporosis than men and suffer fractures earlier. Osteoporosis care is poor in primary care even though good guidelines are available. The Investigators will work with older women and healthcare professionals to help guide the research. They have already looked at published research and will build on this. They will identify what is important for both older women and professionals to inform the first interview questions. The Investigators will ask older women and healthcare professionals about the diagnosis and treatment of osteoporosis. They will also ask them how they manage osteoporosis as a patient or care provider. At regular intervals, the Investigators will look at the interview findings first and then share their thoughts with older women and professionals. Together they will explore what the interviews mean. These discussions may change the questions asked and who is interviewed next. The Investigators will combine all the information from interviews to identify what works well and less well in osteoporosis care. They will check these findings against the guidelines. They will continue to work with older women and healthcare professionals to develop recommendations for improving care. The Investigators will also identify areas of further work. They will share recommendations with healthcare commissioners and produce a summary for a variety of professional networks. They will also publish papers in journals aimed at healthcare professionals and produce a summary document and advice for older women to use.

Eligibility Criteria

Inclusion Criteria Older women: * Osteoporosis diagnosis - either self-reported following a clinical diagnosis or taken from the patient's medical record in the case of the Community Ageing Research 75+ (CARE75+) cohort and Fracture Liaison Service (FLS) patients. * Aged 70 years or older to align with the recommendation from our preliminary engagement work. * Community dwelling. Healthcare professionals: • Working in the National Health Service (NHS) in England to align with the participant sample. Exclusion criteria Older women: * Aged under 70 years. * Lacks capacity to consent to participate in research. * Resident in a care home - care home residents are likely to need different types of interventions than community dwelling older women as there are organisational considerations. * Member of the co-production workshop. Healthcare professionals: * Not performing any NHS work. * \< 12 months in NHS practice.

Contact & Investigator

Central Contact

Anne Heaven, MPhil

✉ anne.heaven@bthft.nhs.uk

📞 +44 1274382815

Principal Investigator

Anne Heaven, MPhil

PRINCIPAL INVESTIGATOR

Bradford Institute for Health Research

Frequently Asked Questions

Who can join the NCT06431867 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06431867 currently recruiting?

Yes, NCT06431867 is actively recruiting participants. Contact the research team at anne.heaven@bthft.nhs.uk for enrollment information.

Where is the NCT06431867 trial being conducted?

This trial is being conducted at Bradford, United Kingdom.

Who is sponsoring the NCT06431867 clinical trial?

NCT06431867 is sponsored by Bradford Institute for Health Research. The principal investigator is Anne Heaven, MPhil at Bradford Institute for Health Research. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology